Parallax Volatility Advisers
FMI

Parallax Volatility Advisers’s Foundation Medicine, Inc. FMI Stock Holding History

Parallax Volatility Advisers’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-170,000
Closed -$6.76M – 3760
2017
Q2 		$6.76M Buy
+170,000
New +$6.22M 0.01% 494

Other funds holding FMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Parallax Volatility Advisers's FMI Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Foundation Medicine, Inc. (FMI) in Q1 2018, closing a stake of 2,226 shares — an estimated $164K sold.

Parallax Volatility Advisers first reported a position in FMI in Q3 2017 and held it in 2 quarters. The position peaked at $245K in Q3 2017. 144 funds tracked by Wall St. Rank hold FMI as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Foundation Medicine, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,226 Foundation Medicine, Inc. shares in Q1 2018, an estimated $164K.
  • Parallax Volatility Advisers first reported a position in Foundation Medicine, Inc. in Q3 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Foundation Medicine, Inc. position peaked at $245K in Q3 2017.
  • 144 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.